All Solutions
Biotech and Life Sciences
Orphan Drug Credit
Seeking treatments to rare diseases can seem challenging for drug developers. The Orphan Drug Credit is a powerful government tax incentive that empowers your efforts through valuable savings that can stack with R&D Tax Credits.
Power Your Efforts to Develop Treatments for Rare Diseases
Pharmaceutical companies face significant financial challenges when
developing treatments for rare diseases, often called “orphan diseases”.
With limited patient populations, these endeavors can seem economically
unviable. The Orphan Drug Tax Credit (ODC) addresses this by offering a
substantial tax incentive to encourage investment in life-saving treatments.
